首页 | 本学科首页   官方微博 | 高级检索  
     

前列腺素E1脂微球载体制剂治疗慢性重型肝炎的MELD评分变化
引用本文:纪 民,金 萍,李 巍,张雪松. 前列腺素E1脂微球载体制剂治疗慢性重型肝炎的MELD评分变化[J]. 大连医科大学学报, 2008, 30(3): 257-259
作者姓名:纪 民  金 萍  李 巍  张雪松
作者单位:1. 大连市第六人民医院ICU,宁大连,116001
2. 大连医科大学附属第二医院感染科,辽宁大连,116027
3. 大连医科大学附属第二医院,辽宁大连,116027
摘    要:[目的]应用终末期肝病模型(MELD评分)评价前列腺素E1脂微球载体制剂(Lipo PGE1)对慢性重型肝炎的治疗作用。[方法]108例慢性重型肝炎随机分成治疗组、对照组,对照组53例予一般综合治疗,治疗组55例在一般综合治疗基础上加用Lipo PGE120μg/d,疗程4周,观察两组治疗前后MELD评分的变化。[结果]治疗组患者治疗后MELD评分(22.18±10.08),与治疗前MELD评分(28.36±7.61)相比明显下降,差异有显著性意义,P〈0.05;与对照组治疗后的评分(27.82±9.64)相比差异也有显著性意义,P〈0.05。[结论]Lipo PGE1对慢性重型肝炎有明显疗效,可改善病人的短期预后。

关 键 词:前列腺素E1脂微球载体制剂  慢性重型肝炎  MELD评分
文章编号:1671-7295(2008)03-0257-03
修稿时间:2008-02-28

Changes of MELD score in patients with chronic severe hepatitis treated by Lipo-prostaglandin E1
JI Min,JIN Ping,LI Wei and ZHANG Xue-shong. Changes of MELD score in patients with chronic severe hepatitis treated by Lipo-prostaglandin E1[J]. Journal of Dalian Medical University, 2008, 30(3): 257-259
Authors:JI Min  JIN Ping  LI Wei  ZHANG Xue-shong
Affiliation:1.Department of ICU;the Sixth People Hospital of Dalian;Dalian 116001;China;2.Department of Infection Disease;the Second Affiliated Hospital of Dalian Medical University;Dalian 116027;3.Department of Interventional;China
Abstract:[Objective]To investigate the effect of Lipo PGE1 on patients with chronic sereve hepatitis by MELD(Model for end-stage live disease) prognosis analysis.[Methods]One hundred and eight patients with chronic severe hepatitis were divided randomly into treatment group and control group.53 patients in the control group received general routine treatments,55 patients in the treatment group received general routine treatments and Lipo PGE1 for 4 weeks,the MELD score and prognosis of diease were assessed between t...
Keywords:Lipo-prostaglandin E1  chronic severe hepatitis  Model of end-stage liver disease  
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《大连医科大学学报》浏览原始摘要信息
点击此处可从《大连医科大学学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号